DENTSPLY SIRONA (XRAY) director adds common shares and phantom stock units

Rhea-AI Filing Summary

DENTSPLY SIRONA Inc. director Jonathan Jay Mazelsky reported routine equity awards tied to his board service. On January 9, 2026, he acquired 395.158 shares of common stock at $0, representing dividends paid on his existing restricted stock units (RSUs). These dividend RSUs follow the same vesting schedule as the underlying RSUs and each RSU converts into one share of common stock. After this transaction, he beneficially owned 28,846.534 common shares directly.

On the same date, he also acquired 153.7009 phantom stock units under the directors' deferred compensation program at an assigned value of $12.22 per unit, increasing his directly held phantom stock balance to 14,535.2138 units. Each phantom stock unit is economically equivalent to one share of common stock and becomes payable in common stock when his service as a director ends.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider MAZELSKY JONATHAN JAY

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Phantom Stock (Directors' Deferred Compensation) DDC	153.701	$12.22	$2K
Grant/Award	Common Stock	395.158	$0.00	--

Holdings After Transaction: Phantom Stock (Directors' Deferred Compensation) DDC — 14,535.214 shares (Direct); Common Stock — 28,846.534 shares (Direct)

Footnotes (1)

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director. Comprised of phantom stock acquired as a result of accrued dividends.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MAZELSKY JONATHAN JAY

(Last) (First) (Middle)

C/O DENTSPLY SIRONA INC

13320-B BALLANTYNE CORPORATE PLACE

(Street)

CHARLOTTE NC 28277

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
DENTSPLY SIRONA Inc. [ XRAY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/09/2026		A		395.158(1)	A	$0	28,846.534	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Phantom Stock (Directors' Deferred Compensation) DDC	(2)	01/09/2026		A		153.7009(3)		(2)	(2)	Common Stock	153.7009	$12.22	14,535.2138	D

Explanation of Responses:

1. Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis.

2. Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of service as a director.

3. Comprised of phantom stock acquired as a result of accrued dividends.

	/s/ Jessica Nielsen Causey, Attorney-in-Fact for Jonathan Jay Mazelsky	01/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider activity did DENTSPLY SIRONA (XRAY) disclose for Jonathan Jay Mazelsky?

DENTSPLY SIRONA reported that director Jonathan Jay Mazelsky acquired 395.158 shares of common stock at $0 and 153.7009 phantom stock units on January 9, 2026, all held directly.

How many DENTSPLY SIRONA common shares does Jonathan Jay Mazelsky own after this transaction?

Following the reported acquisition of dividend-related RSUs on January 9, 2026, Jonathan Jay Mazelsky beneficially owned 28,846.534 shares of DENTSPLY SIRONA common stock directly.

What are the terms of the RSU dividends reported by DENTSPLY SIRONA (XRAY)?

The 395.158 common shares reflect dividends on existing RSUs, credited as additional RSUs. These dividend RSUs vest on the same schedule as the underlying RSU awards, and each RSU converts into one share of common stock.

What is the phantom stock awarded to the DENTSPLY SIRONA director and how does it work?

The filing shows 153.7009 phantom stock units credited to the director's deferred compensation account at $12.22 per unit. Each phantom unit is economically equivalent to one common share and becomes payable in common stock when his service as a director terminates.

How many phantom stock units does the DENTSPLY SIRONA director hold after this Form 4 transaction?

After the January 9, 2026 award, Jonathan Jay Mazelsky directly holds 14,535.2138 phantom stock units under the directors' deferred compensation program.

Were the DENTSPLY SIRONA equity awards to the director related to dividends?

Yes. The common stock amount of 395.158 shares represents dividends on RSUs credited as additional RSUs, and the 153.7009 phantom stock units are described as being comprised of phantom stock acquired from accrued dividends.